OrbiMed Capital GP V LLC

Director at Loxo Oncology, Inc. · on record since Aug 12, 2016
10% owner at TORCH OFFSHORE INC · on record since Apr 9, 2026
Director at Nabriva Therapeutics plc · on record since Dec 30, 2016
10% owner at Nabriva Therapeutics plc · on record since Dec 30, 2016
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
Director at Dimension Therapeutics, Inc. · on record since Oct 29, 2015
10% owner at Dimension Therapeutics, Inc. · on record since Oct 29, 2015
Director at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
Director at Corvus Pharmaceuticals, Inc. · on record since Jun 27, 2016
10% owner at Corvus Pharmaceuticals, Inc. · on record since Jun 27, 2016
10% owner at Spyre Therapeutics, Inc. · on record since Apr 19, 2016
Director at Intellia Therapeutics, Inc. · on record since May 13, 2016
10% owner at Intellia Therapeutics, Inc. · on record since May 5, 2016
Director at Whitehawk Therapeutics, Inc. · on record since Mar 17, 2017
10% owner at Whitehawk Therapeutics, Inc. · on record since Mar 17, 2017
10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 10, 2017
Director at ARMO BioSciences, Inc. · on record since Jan 30, 2018
10% owner at ARMO BioSciences, Inc. · on record since Jan 30, 2018
Director at · on record since Jun 27, 2018
10% owner at · on record since Jun 27, 2018
10% owner at · on record since May 9, 2018
Director at · on record since Oct 19, 2018
Director at · on record since Dec 13, 2018
Director at · on record since Sep 29, 2020
10% owner at · on record since Sep 29, 2020
Director at · on record since Sep 17, 2020
Director at · on record since Jun 23, 2020
10% owner at · on record since Jun 23, 2020

Insider trading activity of OrbiMed Capital GP V LLC

Transactions on record: 51; since Aug 6, 2014

Open-market buys: 12; $20.1M

Open-market sells: 21; $136.9M

Companies traded: 9; last filing Oct 27, 2025

Figures computed from official regulatory filings — .

Companies where OrbiMed Capital GP V LLC has traded

2 tx · $1.9M · Oct 27, 2025
9 tx · $10.5M · May 8, 2024
3 tx · $197.3K · May 10, 2022
12 tx · $19.1M · Nov 17, 2021
3 tx · $62.5K · Dec 10, 2020
6 tx · $80.2M · Aug 19, 2020
5 tx · $2.7M · Jun 6, 2018
4 tx · $4.7M · May 24, 2018
7 tx · $44.2M · Dec 12, 2017

Track record of OrbiMed Capital GP V LLC

Statistical track record

Free account

Open-market buys: 14

Last buy: May 6, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of OrbiMed Capital GP V LLC

Co-insiders of OrbiMed Capital GP V LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PMV Pharmaceuticals, Inc.Listing on record	Oct 27, 2025	Sell	-1,000,000	1.52 USD	$1.5M		SEC
Corvus Pharmaceuticals, Inc.Listing on record	May 8, 2024	BuyD (derivative)	1,397,684	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Corvus Pharmaceuticals, Inc.Listing on record	May 8, 2024	BuyD (derivative)	1,444,085	1.73 USD	$2.5M	ClusterFirst in 12mo	SEC
PMV Pharmaceuticals, Inc.Listing on record	May 31, 2022	Sell	-26,253	15.93 USD	$418.2K		SEC
Compass Therapeutics, Inc.Listing on record	May 10, 2022	Buy	24,447	1.60 USD	$39.1K	conv 33Cluster	SEC
Compass Therapeutics, Inc.Listing on record	May 10, 2022	Buy	90,712	1.56 USD	$141.5K	conv 20	SEC
Compass Therapeutics, Inc.Listing on record	May 10, 2022	Buy	10,200	1.63 USD	$16.6K	conv 32First in 12mo	SEC
Tricida, Inc.Listing unverified	Nov 17, 2021	Award	666,667	6.00 USD	$4M		SEC
Tricida, Inc.Listing unverified	Nov 17, 2021	AwardD (derivative)	666,667	—	n/a (No price was disclosed in the filing)		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Sep 22, 2021	Sell	-1,109,644	6.09 USD	$6.8M		SEC
Whitehawk Therapeutics, Inc.Listing unverified	Dec 10, 2020	OtherD (derivative)	-21,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Whitehawk Therapeutics, Inc.Listing unverified	Dec 10, 2020	Other	21,400	0.96 USD	$20.5K		SEC
Whitehawk Therapeutics, Inc.Listing unverified	Dec 10, 2020	Sell	-21,400	1.96 USD	$41.9K		SEC
Inspire Medical Systems, Inc.Listing on record	Aug 19, 2020	Sell	-43,543	108.54 USD	$4.7M		SEC
Inspire Medical Systems, Inc.Listing on record	Aug 19, 2020	Sell	-94,900	107.49 USD	$10.2M		SEC
Inspire Medical Systems, Inc.Listing on record	Mar 5, 2020	Sell	-400,000	84.42 USD	$33.8M	Unusual size	SEC
Inspire Medical Systems, Inc.Listing on record	Mar 5, 2020	Sell	-25,000	84.55 USD	$2.1M		SEC
Inspire Medical Systems, Inc.Listing on record	Mar 5, 2020	Sell	-75,000	83.21 USD	$6.2M		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Aug 8, 2019	Buy	142,656	3.51 USD	$500.7K	conv 37Cluster	SEC
Tricida, Inc.Listing unverified	Apr 5, 2019	Buy	225,000	36.00 USD	$8.1M	conv 37Unusual size	SEC
Inspire Medical Systems, Inc.Listing on record	Dec 13, 2018	Sell	-614,772	37.60 USD	$23.1M	Unusual size	SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	OtherD (derivative)	-4,255,319	—	n/a (No price was disclosed in the filing)		SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	OtherD (derivative)	-6,207,674	—	n/a (No price was disclosed in the filing)		SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	Buy	368,421	19.00 USD	$7M	conv 58ClusterUnusual size+1	SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	Other	3,591,194	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PMV Pharmaceuticals, Inc.Listing on record	Oct 27, 2025	Sell	-1,000,000	1.52 USD	$1.5M		SEC
Corvus Pharmaceuticals, Inc.Listing on record	May 8, 2024	BuyD (derivative)	1,397,684	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Corvus Pharmaceuticals, Inc.Listing on record	May 8, 2024	BuyD (derivative)	1,444,085	1.73 USD	$2.5M	ClusterFirst in 12mo	SEC
PMV Pharmaceuticals, Inc.Listing on record	May 31, 2022	Sell	-26,253	15.93 USD	$418.2K		SEC
Compass Therapeutics, Inc.Listing on record	May 10, 2022	Buy	24,447	1.60 USD	$39.1K	conv 33Cluster	SEC
Compass Therapeutics, Inc.Listing on record	May 10, 2022	Buy	90,712	1.56 USD	$141.5K	conv 20	SEC
Compass Therapeutics, Inc.Listing on record	May 10, 2022	Buy	10,200	1.63 USD	$16.6K	conv 32First in 12mo	SEC
Tricida, Inc.Listing unverified	Nov 17, 2021	Award	666,667	6.00 USD	$4M		SEC
Tricida, Inc.Listing unverified	Nov 17, 2021	AwardD (derivative)	666,667	—	n/a (No price was disclosed in the filing)		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Sep 22, 2021	Sell	-1,109,644	6.09 USD	$6.8M		SEC
Whitehawk Therapeutics, Inc.Listing unverified	Dec 10, 2020	OtherD (derivative)	-21,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Whitehawk Therapeutics, Inc.Listing unverified	Dec 10, 2020	Other	21,400	0.96 USD	$20.5K		SEC
Whitehawk Therapeutics, Inc.Listing unverified	Dec 10, 2020	Sell	-21,400	1.96 USD	$41.9K		SEC
Inspire Medical Systems, Inc.Listing on record	Aug 19, 2020	Sell	-43,543	108.54 USD	$4.7M		SEC
Inspire Medical Systems, Inc.Listing on record	Aug 19, 2020	Sell	-94,900	107.49 USD	$10.2M		SEC
Inspire Medical Systems, Inc.Listing on record	Mar 5, 2020	Sell	-400,000	84.42 USD	$33.8M	Unusual size	SEC
Inspire Medical Systems, Inc.Listing on record	Mar 5, 2020	Sell	-25,000	84.55 USD	$2.1M		SEC
Inspire Medical Systems, Inc.Listing on record	Mar 5, 2020	Sell	-75,000	83.21 USD	$6.2M		SEC
Corvus Pharmaceuticals, Inc.Listing on record	Aug 8, 2019	Buy	142,656	3.51 USD	$500.7K	conv 37Cluster	SEC
Tricida, Inc.Listing unverified	Apr 5, 2019	Buy	225,000	36.00 USD	$8.1M	conv 37Unusual size	SEC
Inspire Medical Systems, Inc.Listing on record	Dec 13, 2018	Sell	-614,772	37.60 USD	$23.1M	Unusual size	SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	OtherD (derivative)	-4,255,319	—	n/a (No price was disclosed in the filing)		SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	OtherD (derivative)	-6,207,674	—	n/a (No price was disclosed in the filing)		SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	Buy	368,421	19.00 USD	$7M	conv 58ClusterUnusual size+1	SEC
Tricida, Inc.Listing unverified	Jul 2, 2018	Other	3,591,194	—	n/a (No price was disclosed in the filing)		SEC